top of page


NEXT Bio-Research Services Launches

November 10, 2015

NEXT Molecular Analytics officially began operations October 1 in 6000 square feet of leased space in the Ironbridge Medical Park, Chester, VA. NEXT Molecular Analytics continues a 23 year history of providing comprehensive integrated project support to investigators in the biotech and pharmaceutical sectors and in providing medical testing services to physicians using state-of-the-art platforms.


Please reload

Richmond Times-Dispatch Article about NEXT Molecular Analytics

November 12, 2015

NEXT Molecular Analytics article in the business section of the Richmond Times-Dispatch.

Please reload

NEXT Bio-Research Services, LLC is now NEXT Molecular Analytics

February 01, 2016

It’s what we do. It’s who we are. To better identify with our customer base and to better attract new customers, NEXT Bio-Research Services LLC is now doing business as NEXT Molecular Analytics.  Same dedication to serving our customers. Same expertise.  Same devotion to excellence.



New email:

New web address:

Please reload

NEXT Scientists contribute to paper on pharmacogenomics of CYP450 genes

March 15, 2016

NEXT Molecular Analytics (NEXT) announces the publication of a large pharmacogenomics clinical study involving Next Generation Sequencing (NGS) of CytochromeP450 genes from different ethnic populations. The work, lead by three scientist who now work at NEXT (Katie O’Hanlon, Greg Meyers and Tom Reynolds), represents one of the largest studies of its kind. The study, which was performed from 2013-2014 at a previous employer, is entitled “Next Generation Sequencing Reveals Disparate Population Frequencies Among Cytochrome P450 Genes: Clinical Pharmacogenomics of the CYP2 Family”. 

Please reload

bottom of page